Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Oncology
|
June 28, 2022
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
Xin Wang, Osvaldo Espin-Garcia, Di Maria Jiang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2022
Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About
Lucy X Ma, Elan D Panov, Michael J Allen, et al.
Nature Communications
|
May 14, 2024
Long-read powered viral metagenomics in the oligotrophic Sargasso Sea
Joanna Warwick-Dugdale, Funing Tian, Michelle L Michelsen, et al.
Science (New York, N.Y.)
|
August 16, 2005
Complete genome sequence and lytic phase transcription profile of a Coccolithovirus
William H Wilson, Declan C Schroeder, Michael J Allen, et al.
Cancers
|
January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus
Thiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
The Oncologist
|
November 15, 2022
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
Lucy X Ma, Osvaldo Espin-Garcia, Yvonne Bach, et al.
The Oncologist
|
July 24, 2024
Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy
Xin Wang, Michael J Allen, Osvaldo Espin-Garcia, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency
Alan D Borthwick, Dave E Davies, Anne M Exall, et al.
Journal of Clinical Pathology
|
September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature
Michael J Allen, Amy Zhang, Prashant Bavi, et al.
Journal of Medicinal Chemistry
|
January 14, 2012
Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency
Alan D Borthwick, John Liddle, Dave E Davies, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Oncology
|
June 28, 2022
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
Xin Wang, Osvaldo Espin-Garcia, Di Maria Jiang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2022
Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About
Lucy X Ma, Elan D Panov, Michael J Allen, et al.
Nature Communications
|
May 14, 2024
Long-read powered viral metagenomics in the oligotrophic Sargasso Sea
Joanna Warwick-Dugdale, Funing Tian, Michelle L Michelsen, et al.
Science (New York, N.Y.)
|
August 16, 2005
Complete genome sequence and lytic phase transcription profile of a Coccolithovirus
William H Wilson, Declan C Schroeder, Michael J Allen, et al.
Cancers
|
January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus
Thiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
The Oncologist
|
November 15, 2022
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
Lucy X Ma, Osvaldo Espin-Garcia, Yvonne Bach, et al.
The Oncologist
|
July 24, 2024
Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy
Xin Wang, Michael J Allen, Osvaldo Espin-Garcia, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency
Alan D Borthwick, Dave E Davies, Anne M Exall, et al.
Journal of Clinical Pathology
|
September 29, 2021
Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature
Michael J Allen, Amy Zhang, Prashant Bavi, et al.
Journal of Medicinal Chemistry
|
January 14, 2012
Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency
Alan D Borthwick, John Liddle, Dave E Davies, et al.
Page
of 12